WO1995021628B1 - Traitement de la diarrhee associee a la prise d'antibiotiques - Google Patents

Traitement de la diarrhee associee a la prise d'antibiotiques

Info

Publication number
WO1995021628B1
WO1995021628B1 PCT/CA1995/000060 CA9500060W WO9521628B1 WO 1995021628 B1 WO1995021628 B1 WO 1995021628B1 CA 9500060 W CA9500060 W CA 9500060W WO 9521628 B1 WO9521628 B1 WO 9521628B1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
oligosaccharide sequence
oligosaccharide
treatment
associated diarrhea
Prior art date
Application number
PCT/CA1995/000060
Other languages
English (en)
Other versions
WO1995021628A1 (fr
Filing date
Publication date
Priority claimed from US08/195,009 external-priority patent/US5484773A/en
Application filed filed Critical
Priority to DE69533084T priority Critical patent/DE69533084T2/de
Priority to CA002181359A priority patent/CA2181359C/fr
Priority to AT95907526T priority patent/ATE267614T1/de
Priority to EP95907526A priority patent/EP0744959B1/fr
Priority to NZ279180A priority patent/NZ279180A/en
Priority to JP52086995A priority patent/JP4122052B2/ja
Priority to AU15727/95A priority patent/AU698275B2/en
Publication of WO1995021628A1 publication Critical patent/WO1995021628A1/fr
Publication of WO1995021628B1 publication Critical patent/WO1995021628B1/fr
Priority to NO963378A priority patent/NO963378L/no

Links

Abstract

L'invention se rapporte au traitement de la diarrhée associée à la prise d'antibiotiques, notamment la diarrhée associée à Clostridium difficile (CDAD) et la colite pseudomembraneuse (PMC), consistant à utiliser des compositions à base d'oligosaccharides qui fixent la toxine A de C. difficile. L'invention concerne plus particulièrement la neutralisation de la toxine A de C. difficile associée à la diarrhée due à C. difficile.
PCT/CA1995/000060 1994-02-14 1995-02-09 Traitement de la diarrhee associee a la prise d'antibiotiques WO1995021628A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE69533084T DE69533084T2 (de) 1994-02-14 1995-02-09 Behandlung von antibiotisch-assoziierte-diarrhöe
CA002181359A CA2181359C (fr) 1994-02-14 1995-02-09 Traitement de la diarrhee associee a la prise d'antibiotiques
AT95907526T ATE267614T1 (de) 1994-02-14 1995-02-09 Behandlung von antibiotisch-assoziierte-diarrhöe
EP95907526A EP0744959B1 (fr) 1994-02-14 1995-02-09 Traitement de la diarrhee associee a la prise d'antibiotiques
NZ279180A NZ279180A (en) 1994-02-14 1995-02-09 Treating clostridium difficile associated diarrhea (cdad) and other antibiotic associated diarrhea using oligosaccharide compositions which bind toxin a
JP52086995A JP4122052B2 (ja) 1994-02-14 1995-02-09 抗生物質関連性下痢の処置
AU15727/95A AU698275B2 (en) 1994-02-14 1995-02-09 Treatment of antibiotic associated diarrhea
NO963378A NO963378L (no) 1994-02-14 1996-08-13 Behandling av antibiotisk assosiert diare

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/195,009 1994-02-14
US08/195,009 US5484773A (en) 1994-02-14 1994-02-14 Treatment of antibiotic associated diarrhea

Publications (2)

Publication Number Publication Date
WO1995021628A1 WO1995021628A1 (fr) 1995-08-17
WO1995021628B1 true WO1995021628B1 (fr) 1995-08-31

Family

ID=22719705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1995/000060 WO1995021628A1 (fr) 1994-02-14 1995-02-09 Traitement de la diarrhee associee a la prise d'antibiotiques

Country Status (15)

Country Link
US (2) US5484773A (fr)
EP (1) EP0744959B1 (fr)
JP (1) JP4122052B2 (fr)
KR (1) KR970701064A (fr)
CN (1) CN1131070C (fr)
AT (1) ATE267614T1 (fr)
AU (1) AU698275B2 (fr)
CA (1) CA2181359C (fr)
DE (1) DE69533084T2 (fr)
IL (1) IL112428A (fr)
MX (1) MX197129B (fr)
NO (1) NO963378L (fr)
NZ (1) NZ279180A (fr)
WO (1) WO1995021628A1 (fr)
ZA (1) ZA95630B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231675T2 (de) * 1991-10-18 2001-06-28 Synsorb Biotech Inc Behandlung bakterieller dysenterie
DE4428056A1 (de) * 1994-07-29 1996-02-08 Schering Ag Verwendung von Mikropartikelpräparationen zur Eliminierung gelöster, nicht nierengängiger Substanzen aus dem Blut
US6140045A (en) * 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5811409A (en) * 1995-06-05 1998-09-22 Synsorb Biotech, Inc. Treatment of cholera
US5661131A (en) * 1995-06-05 1997-08-26 Synsorb Biotech, Inc. Treatment of cholera
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US6069137A (en) * 1996-03-11 2000-05-30 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5891860A (en) * 1996-03-11 1999-04-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
JPH107575A (ja) * 1996-06-21 1998-01-13 Synsorb Biotec Inc 細菌性赤痢の処置
US6013634A (en) * 1996-11-08 2000-01-11 Synsorb Biotech, Inc. Solid support matrices containing a toxin binding oligosaccharide
US5846943A (en) * 1996-11-08 1998-12-08 Synsorb Biotech, Inc. Solid support matricles containing a toxin binding oligosaccharide
US5968907A (en) * 1996-11-14 1999-10-19 Synsorb Biotech, Inc. 1-thiogalactose derivatives
US6063769A (en) * 1996-11-14 2000-05-16 Synsorb Biotech, Inc. 1-thiogalactose derivatives
US5932554A (en) * 1996-11-14 1999-08-03 Synsorb Biotech, Inc. 1-galactose derivatives
US6087339A (en) * 1996-11-14 2000-07-11 Synsorb Biotech, Inc. Saccharide derivatives
NZ332975A (en) * 1996-11-15 2001-06-29 Synsorb Biotech Inc Combinatorial synthesis of carbohydrate libraries
US5965719A (en) * 1996-11-15 1999-10-12 Sunsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
US6174867B1 (en) 1998-05-08 2001-01-16 Synsorb Biotech, Inc. 1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage
US6358930B1 (en) * 1998-05-28 2002-03-19 Synsorb Biotech Inc. Treatment of C. difficile toxin B associated conditions
US6013635A (en) * 1998-05-28 2000-01-11 Synsorb Biotech, Inc. Treatment of C. difficile toxin B associated conditions
US6291435B1 (en) * 1999-03-04 2001-09-18 The Governs Of The University Of Alberta Treatment of diarrhea caused by enteropathogenic Escherichia coli
US6290946B1 (en) * 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (fr) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Polymeres anioniques utilises comme agents antibacteriens specifiques de certaines especes
US6596707B2 (en) * 2001-05-24 2003-07-22 Abbott Laboratories Monovalent saccharides and uses thereof
CN101319023A (zh) * 2002-07-22 2008-12-10 基酶有限公司 聚(钾和钠的苯乙烯苯磺酸盐),其制备及其用途
US7682631B2 (en) * 2003-10-01 2010-03-23 Clemson University Adhesin-specific nanoparticles and process for using same
JP5236189B2 (ja) * 2003-12-05 2013-07-17 チルドレンズ ホスピタル メディカル センター オリゴ糖組成物および感染症の治療における該組成物の使用
US20060078534A1 (en) * 2004-10-13 2006-04-13 Dominique Charmot Toxin binding compositions
WO2006044577A1 (fr) * 2004-10-13 2006-04-27 Ilypsa, Inc. Préparations pharmaceutiques comprenant un oligosaccharide complexant les toxines et une particule polymère
CA2608505C (fr) * 2005-05-18 2013-12-24 Da Volterra Administration colonique d'adsorbants
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
WO2007114683A1 (fr) * 2006-03-30 2007-10-11 N.V. Nutricia Oligosaccharides de lait destinés à stimuler le système immunitaire
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
US20080041643A1 (en) * 2006-08-17 2008-02-21 Khalife Tony N Wind-power vehicle aka WPV
CA2698374C (fr) 2007-09-07 2018-04-03 Children's Hospital Medical Center Utilisation des taux d'antigene secreteurs, lewis et sialyle dans des echantillons cliniques comme predicteurs de risque de maladie
CA2767043C (fr) 2009-07-06 2020-07-14 Children's Hospital Medical Center Inhibition de l'inflammation par des oligosaccharides du lait
WO2014130789A1 (fr) 2013-02-21 2014-08-28 Children's Hospital Medical Center Utilisation de glycanes et de glycosyltransférases pour le diagnostic ou la surveillance d'une affection abdominale inflammatoire
WO2016176484A1 (fr) 2015-04-28 2016-11-03 Children's Hospital Medical Center Utilisation de compositions d'oligosaccharides pour améliorer la prise de poids
CN108977497A (zh) * 2018-06-12 2018-12-11 深圳市领治医学科技有限公司 一种采集和保存人痕量粪便样本的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
DE2857790C2 (de) * 1977-04-14 1983-12-22 Chembiomed Ltd., Edmonton, Alberta Verfahren zur Herstellung von O-geschützten 2-Azido-2-desoxy-glycosylhalogeniden, einige derartige Verbindungen als solche und deren Verwendung
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
US4713240A (en) * 1985-04-04 1987-12-15 Research Corporation Vaccines based on insoluble supports
US4863852A (en) * 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
US5098826A (en) * 1990-03-09 1992-03-24 Virginia Tech Intellectual Properties, Inc. Detection, isolation and purification of Clostridium difficile toxin A with toxin receptors
US5266315A (en) * 1990-05-07 1993-11-30 Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho Composite for Clostridium difficile diarrhea and pseudomembranous colitis
DE69231675T2 (de) * 1991-10-18 2001-06-28 Synsorb Biotech Inc Behandlung bakterieller dysenterie

Similar Documents

Publication Publication Date Title
WO1995021628B1 (fr) Traitement de la diarrhee associee a la prise d'antibiotiques
CA2181359A1 (fr) Traitement de la diarrhee associee a la prise d'antibiotiques
Malabarba et al. Glycopeptide derivatives
CA2118757A1 (fr) Composes a base d'azacyclohexapeptide
WO2000059528A8 (fr) Antibiotiques glycopeptidiques des-leucyl et procede de preparation
WO1994008624A3 (fr) Procedes et compositions d'imagerie diagnostique et therapeutique
EP1089740B8 (fr) Composés destinés au traitement de la diahree causé par la toxine b de c. difficile (cdad)
CA2243504A1 (fr) Nouveaux derives de 19-nor-pregnene
HU9502084D0 (en) Polymer-bound camptothecin derivatives
IL134056A0 (en) Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
WO2001010951A8 (fr) Compositions de polymeres styreniques antistatiques
CA2053832A1 (fr) Plastifiants stables pour compositions de type nitrocellulose/nitroguanidine
IL117656A (en) Pharmaceutical compositions comprising a supported saccharide for the treatment of travellers' diarrhea caused by E.coli LT enterotoxin
WO1998056398A3 (fr) Methode de traitement de maladies diarrheiques et d'elimination de certaines populations bacteriennes du colon
ES8705893A1 (es) Un procedimiento para preparar derivados monoamidicos basicos de actagardina
CA2251086A1 (fr) Composes glycopeptidiques
NZ332976A (en) Solid support matrices containing a toxin binding oligosaccharide
NZ302632A (en) Treatment of traveller's diarrhea using a pharmaceutical composition containing a saccharide sequence
Ahrendt et al. Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue
WO2004056849B1 (fr) Methanobactine: compose de fixation du cuivre ayant une action antibiotique et antioxydante isole a partir de la bacterie methanotrophique
WO2001032219A3 (fr) Traitement de pathologies associees aux toxines b de c. difficile
CA2136438A1 (fr) Conjugues d'anthracycline, leur preparation et leur utilisation en tant qu'agent antitumoral
CA2106675A1 (fr) Procede de preparation enzymatique de macrolactone
NZ504303A (en) Compounds and methods for the e coli mediated dysentery using antibiotics and shiga like toxin binding oligosaccharide compositions
EP0326873A3 (fr) Hydrazides de la téichoplanine